Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share - Schedule of potential common shares (Details)

v3.24.2.u1
Net Income (Loss) Per Share - Schedule of potential common shares (Details) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 1,690,695 3,885,324 1,738,251 3,885,324
Warrants to Purchase Common Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 853,330 853,330 853,330 853,330
PSUs, RSUs and Options to Purchase Common Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 254,032 2,448,661 301,588 2,448,661
Right to Receive Earnout Shares [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 583,333 583,333 583,333 583,333